A strategic plan of Shandong Pharmaceutical Company Limited

Gao Yan

Date of Publication

2006

Document Type

Oral Comprehensive Exam

Degree Name

Master of Business Administration

College

Ramon V. Del Rosario College of Business

Department/Unit

Decision Sciences and Innovation

Defense Panel Chair

Mundy Gonzalez

Abstract/Summary

The paper primarily scans the current business environment of the pharmaceutical industry in China and anticipates the future changes within the macro environment, which will bring either opportunities or threats to the industry. The Paper then examines the internal strengths and weaknesses of Shandong Pharmaceutical Company.

Based on the proposed Vision Statement of the company, the Paper proposes the following corporate objectives:

1. To increase ROI from -4.14% in 2004 to 2%, 5% and 8% in years 2005, 2006 and 2007, respectively.

2. To achieve RMB 40 million for net profit by the end of 2006 and maintain 60% annual increase.

3. For year 2005, to reach sales of RMB1.74 billion, a 15% increase from RMB1.5 billion in year 2004, and maintain the same increase percentage in 2006 and 2007.

Abstract Format

html

Language

English

Format

Electronic

Accession Number

CDOCE00952

Shelf Location

Archives, The Learning Commons, 12F Henry Sy Sr. Hall

Physical Description

1 computer optical disc ; 4 3/4 in.

Keywords

Pharmaceutical industry--China; Shandong Pharmaceutical Company Limited

This document is currently not available here.

Share

COinS